Literature DB >> 31487392

Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation.

Razan Mohty1, Eolia Brissot1,2, Giorgia Battipaglia1, Annalisa Ruggeri1, Rémy Dulery1, Agnès Bonnin1, Clémence Médiavilla1, Simona Sestili1, Ramdane Belhocine1, Anne Vekhoff1, Tounes Ledraa1, Camelia Simona Lapusan1, Rosa Adaeva1, Françoise Isnard1, Olivier Legrand1, Mohamad Mohty1,2, Florent Malard1,2.   

Abstract

Entities:  

Keywords:  haploidentical stem cell transplantation; infections; infectious complications; post-transplant cyclophosphamide

Mesh：

Substances：

Year:  2019        PMID： 31487392     DOI： 10.1111/bjh.16189

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies.

Authors:  Moniek A de Witte; Anke Janssen; Klaartje Nijssen; Froso Karaiskaki; Luuk Swanenberg; Anna van Rhenen; Rick Admiraal; Lotte van der Wagen; Monique C Minnema; Eefke Petersen; Reinier A P Raymakers; Kasper Westinga; Trudy Straetemans; Constantijn J M Halkes; Jaap-Jan Boelens; Jürgen Kuball
Journal:  Blood Adv       Date:  2021-01-12

2.  Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.

Authors:  Benedetta Rambaldi; Haesook T Kim; Carol Reynolds; Sharmila Chamling Rai; Yohei Arihara; Tomohiro Kubo; Leutz Buon; Mahasweta Gooptu; John Koreth; Corey Cutler; Sarah Nikiforow; Vincent T Ho; Edwin P Alyea; Joseph H Antin; Catherine J Wu; Robert J Soiffer; Jerome Ritz; Rizwan Romee
Journal:  Blood Adv       Date:  2021-01-26

3.  High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graft.

Authors:  Nicolas Stocker; Béatrice Gaugler; Myriam Labopin; Agathe Farge; Yishan Ye; Laure Ricard; Eolia Brissot; Remy Duléry; Simona Sestili; Giorgia Battipaglia; Clémence Médiavilla; Annalisa Paviglianiti; Anne Banet; Zoe Van De Wyngaert; Tounes Ledraa; Mohamad Mohty; Florent Malard
Journal:  Clin Transl Immunology       Date:  2020-09-23

4.  Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT.

Authors:  Elisa Zaghi; Michela Calvi; Simone Puccio; Gianmarco Spata; Sara Terzoli; Clelia Peano; Alessandra Roberto; Federica De Paoli; Jasper Jp van Beek; Jacopo Mariotti; Chiara De Philippis; Barbara Sarina; Rossana Mineri; Stefania Bramanti; Armando Santoro; Vu Thuy Khanh Le-Trilling; Mirko Trilling; Emanuela Marcenaro; Luca Castagna; Clara Di Vito; Enrico Lugli; Domenico Mavilio
Journal:  JCI Insight       Date:  2021-06-22

5.  Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia.

Authors:  Irtiza N Sheikh; Shaikha Alqahtani; Dristhi Ragoonanan; Priti Tewari; Demetrios Petropoulos; Kris M Mahadeo; Uday Popat; Elizabeth J Shpall; Sajad Khazal
Journal:  Int J Mol Sci       Date:  2022-08-06       Impact factor: 6.208

6.  Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching.

Authors:  Sierra Jorge; Martino Rodrigo; García-Cadenas Irene; Esquirol Albert; Bosch-Vilaseca Anna; Awol Rahinatu; Novelli Silvana; Saavedra Silvana; Garrido Ana; López Jordi; Caballero Ana Carolina; Granell Miquel; Moreno Carolina; Briones Javier
Journal:  Bone Marrow Transplant       Date:  2020-10-26       Impact factor: 5.483
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.